
Journal of Organic Chemistry p. 2908 - 2913 (1990)
Update date:2022-08-03
Topics:
Conn, Robin S. Eichen
Douglas, Alan W.
Karady, Sandor
Corley, Edward G.
Lovell, Alfred V.
Shinkai, Ichiro
During preparation of a pharmaceutically active, N-benzylated indole derivative from 4-keto acid and N1-benzylated phenylhydrazine precursors, the N-unsubstituted indole analogue arose as a significant byproduct.The proportion of debenzylated indole was greater with α-alkylated rather than straight-chain keto acids and the byproduct was fully suppressed when a keto ester was substituted for the keto acid.The benzylic group was shown to have eliminated as the amine and 15N label incorporation demonstrated terminal phenylhydrazine nitrogen incorporation in the indole byproduct only, an exception to the usual course of the Fischer indolization reaction.A ring-chain equilibration in the ketimino acid intermediate is proposed to account for the competing pathway.
View MoreNanjing HuiBaiShi Biotechnology Co.,Ltd.
Contact:+86 (25)58745219
Address:No.606 Ningliu Road,LiuHe District.
Shijiazhuang City Xiehe Pharmaceutical Co., Ltd
Contact:+86-311-80817929
Address:Shangzhuang,Shijiazhuang,China
ANHUI CHEM-BRIGHT BIOENGINEERING CO.,LTD
Contact:86-561-4080321
Address:No.8 Lieshan Industrial Zone of Huaibei
Nanjing Norris Pharm Technology Co., Ltd.
Contact:+86-13901585132
Address:2 Qiande Road, Jiangning sciencepark Hi-Tech Zone, Nanjing, P.R.China
Yangzhou Zhongbao Pharmaceutical Co.,Ltd
Contact:+86-514-88290838
Address:Jiangsu Baoying county economic develpment zone in baoying avenue91
Doi:10.1016/S0968-0896(97)10020-7
(1998)Doi:10.1016/S0040-4039(01)99122-1
(1968)Doi:10.1016/S0040-4039(98)00114-2
(1998)Doi:10.3987/com-97-s83
(1997)Doi:10.1055/s-1998-1643
(1998)Doi:10.1039/b403759f
(2004)